Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer Ventures
Biotech
Pfizer Ventures gets behind Chinese biotech's $100M series A
Pfizer’s VC arm has backed a $100 million raise for OTR as the Chinese biotech tacks on preclinical neurological assets to its varied portfolio.
James Waldron
Dec 5, 2025 4:20am
Triana crafts $120M series B to take glue degrader into clinic
Dec 3, 2025 10:35am
MHRA CEO Raine to depart in Autumn —Chutes & Ladders
Mar 1, 2024 9:30am
Pfizer among investors raising Nimbus $125M for phase 3 launch
Sep 12, 2022 11:00am
ReCode breaks the mold with $120M financing, Big Pharma backing
Jun 29, 2022 6:00am
Racing Sanofi, ImmunOs bags $74M for myeloid checkpoint trials
Jun 7, 2022 8:30am
